Revenues in the biopharma industry continued to boom in the fourth quarter of last year, following a pattern seen increasingly throughout 2024. | Revenues in the biopharma industry continued to boom ...
Institutional Class shares of Columbia Dividend Income Fund returned -1.34% for Q4 2024. Click here to read the full ...
For Elevance Health and other big insurers, 2024 devolved into something of an annus horribilis over the year’s final weeks.
With a market cap of $90.6 billion, Elevance Health, Inc. (ELV) is a leading health benefits company, providing comprehensive ...
Reports Q4 revenue $201.81M, consensus $192.14M. “We fired on all cylinders throughout 2024, delivering remarkable revenue growth and upgrading ...
In the fourth quarter of 2024, BB Biotech shares posted a total return of -2.7% in CHF and -3.5% in EUR. NAV performance improved, rising by 2.7% in CHF and 2.8% in EUR, though it declined by 4.3% in ...
Seaport Res Ptn analyst J. Campbell now forecasts that the company will earn $0.07 per share for the quarter, up from their ...
The Madison Investors Fund (class I) decreased 0.4% in the fourth quarter of 2024, compared to the 2.4% increase in the S&P ...
The oncology testing specialist reported strong top-line growth, but also rising costs and ongoing net losses.